494 related articles for article (PubMed ID: 20236804)
1. Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.
Liu WL; Hung YL; Lin SH; Lee PI; Hsueh PR
Int J Antimicrob Agents; 2010 Jun; 35(6):615-6. PubMed ID: 20236804
[No Abstract] [Full Text] [Related]
2. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
3. Fatal bacteraemia caused by daptomycin-non-susceptible, vancomycin-intermediate, meticillin-resistant Staphylococcus aureus in a patient with chronic kidney disease.
Kuo CC; Wu VC; Huang YT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2009 Jan; 33(1):96-8. PubMed ID: 18790610
[No Abstract] [Full Text] [Related]
4. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
5. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
6. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
[No Abstract] [Full Text] [Related]
7. [Consensus document for the treatment of bacteremia and endocarditis caused by methicillin-resistent Staphylococcus aureus. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica].
Gudiol F; Aguado JM; Pascual A; Pujol M; Almirante B; Miró JM; Cercenado E; Domínguez Mde L; Soriano A; Rodríguez-Baño J; Vallés J; Palomar M; Tornos P; Bouza E;
Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):105-15. PubMed ID: 19254641
[TBL] [Abstract][Full Text] [Related]
8. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
10. Increased rifampicin resistance in blood isolates of meticillin-resistant Staphylococcus aureus (MRSA) amongst patients exposed to rifampicin-containing antituberculous treatment.
Tan CK; Lai CC; Liao CH; Lin SH; Huang YT; Hsueh PR
Int J Antimicrob Agents; 2011 Jun; 37(6):550-3. PubMed ID: 21482080
[TBL] [Abstract][Full Text] [Related]
11. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
14. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.
Jacobson LM; Milstone AM; Zenilman J; Carroll KC; Arav-Boger R
Pediatr Infect Dis J; 2009 May; 28(5):445-7. PubMed ID: 19295462
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment.
Tan CK; Lai CC; Lin SH; Hsueh PR
Crit Care Med; 2010 Aug; 38(8):1754; author reply 1754-5. PubMed ID: 20647809
[No Abstract] [Full Text] [Related]
17. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections.
Deresinski S
Clin Infect Dis; 2009 Oct; 49(7):1072-9. PubMed ID: 19725789
[TBL] [Abstract][Full Text] [Related]
18. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus bloodstream infections: definitions and treatment.
Corey GR
Clin Infect Dis; 2009 May; 48 Suppl 4():S254-9. PubMed ID: 19374581
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.
Barber KE; Rybak MJ; Sakoulas G
J Antimicrob Chemother; 2015 Jan; 70(1):311-3. PubMed ID: 25125677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
